Ask your questionclose
* - Required fields

The Third Annual Reproductive, Genetic & Biotechnology conference was held in Riga

On October 20, 2017, Infertility Treatment and Reproductive Genetics clinic iVF Riga together with iVF Riga Stem Cell Centre organized and hosted the Third Annual International Reproductive, Genetic & Biotechnology Conference. More than 170 people took part in the conference. The conference aroused great interest not only among doctors-geneticists, gynecologists, oncologists, reproductive specialists, traumatologists, but also among biotechnologists, embryologists, laboratory specialists, midwives and students. Delegates of the conference were not only from Latvia, but also from Estonia, Lithuania, Sweden, Austria and Russia.
IVF Riga

Dr. Violeta Fodina, Head and the leading specialist of the iVF Riga clinic, in her welcoming speech at the opening of the conference, focused on the rapid development of modern medicine in the field of stem cells and genetics; the importance of using personalized medicine in the treatment of patients and the need for the development of cellular technology in Latvia.
The reports of the conference speakers affecting various aspects of cell technologies and regenerative medicine, as well as genetics and reproductive medicine, have attracted the attention of participants of the conference. Speakers of the conference have represented such countries as Latvia, Israel, Sweden, Norway, Belgium, Lithuania, Spain, United Kingdom.
The chairman of the first session dedicated to stem cell issues was Dr.  Moshe Israeli, Director of Tissue Typing Laboratory, Rabin Medical Center, Israel.
Of particular interest was Fillipo Zambelli’s, PhD (Research Group Reproduction and Genetics, Faculty of Medicine and Pharmacy, Vrije University, Brussel (VUB), Belgium) topic about Stem cells transplantation in treating erectile dysfunction. Mr. Zambelli gave the results of preclinical trials, and also provided intermediate results of clinical trials - cases of stem cell transplantation in uterine restoration and with Asherman's syndrome. 
Adomas Bukauskas, M.D. from Vilnius University Hospital Santaros Klinikos (Vilnius, Lithuania) spoke about clinical applications of mesenchymal stem cells in cases of steroid refractory acute graft versus host disease.
The chairman of the second session dedicated to genetics was Virpi Tohonen, PhD, Scientific coordinator of Center for inborn errors of metabolism, Karolinska University hospital and Department of Molecular Medicine and Surgery, Karolinska Institutet (Sweden). The following topics were touched upon at this session: “Genetic startup of the human embryo”; Dr. Liene Kornejeva (clinical geneticist, iVF Riga, Latvia) gave the results of implementation of molecular investigation in clinical practice. 
Doctors Rosalind Hastings and Katrina Rack of the Cytogenetics External Quality Assessment Service (United Kingdom) highlighted topics such as “Genetic and cytogenetic testing of haemato-oncological malignancies” and “Quality improvement in prenatal and preimplantation genetic diagnostics”.
Dr. Zita Krūmiņa, experienced specialist from Riga Stradiņš University, Department of Biology and Microbiology, Latvia, with “Case reports about stem cell transplantation in rare genetic disorders” made a particular impression on the participants of the conference. In her topic, Dr. Krūmiņa told about certain cases of application of allogeneic stem cells in the treatment of complicated genetic diseases in children and noted that it is necessary to think about the possibility of creating a donor registry of cord blood stem cells in Latvia for the treatment of children with various genetic diseases. 
In addition, the participants of the conference had the opportunity to be acquainted with the equipment, products and services, which companies as SIA Merck, SIA Biosan, SIA Fima, A/S Origio, Gedeon Richter, Vitrolife Sweden AB, OU Inbio, SIA BioAvots, SIA Medilink, SIA BENU, SIA AGA, SIA Interlux, UAB ViaMedPharma can provide for the successful work of medical institutions and laboratories.
It should be emphasized that, in general, all participants and guests noted the high international level of organization and holding of this conference, appreciated the importance of such events for the development of personalized medicine in Latvia.